Therefore, our study suggests yet unknown UPS subunits to play a potential role in cardiac hypertrophy, however due to our experimental design, our results can’t assign our screening hits, e.g., Fbxo25 to either physiological or pathophysiological cardiac hypertrophy. The gene discussed is FBXO25; the disease is cardiac hypertrophy.